TIDMROQ

RNS Number : 8571P

Roquefort Therapeutics PLC

22 June 2022

22 June 2022

Roquefort Therapeutics plc

("Roquefort Therapeutics" or the "Company")

Issue of Warrants

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, announces the following issue of warrants to recently appointed Non-Executive Directors and an advisor to the Board:

 
                               Position   Number of Warrants        Total Number 
   Name                                               Issued    of Warrants Held 
                                                                     After Issue 
                          Non-Executive 
 Ms Jean Duvall                Director              300,000             300,000 
                        ---------------  -------------------  ------------------ 
                          Non-Executive 
 Dr Simon Sinclair(1)          Director              300,000             300,000 
                        ---------------  -------------------  ------------------ 
 Prof. Trevor Jones       Board Advisor              300,000             300,000 
                        ---------------  -------------------  ------------------ 
 

(1) Warrants held in the name of Livingstone Investment Holdings Ltd, a company in which Dr Sinclair has a beneficial interest

The warrants have been issued in relation to the appointment of the abovenamed earlier this year and form part of their annual remuneration package.

The warrants have a term of 5 years and are exercisable at a price of 15 pence, with 50% exercisable after 12 months and the balance exercise after 24 months.

Enquiries:

 
 Roquefort Therapeutics plc 
                                          +44 (0)20 3290 
 Stephen West (Chairman)                            9339 
 Buchanan (Public Relations) 
  Ben Romney / Jamie Hooper / George 
  Beale 
                                          +44 (0)20 7466 
  Optiva Securities Limited (Broker)                5000 
                                          +44 (0)20 3411 
 Christian Dennis                                   1881 
 

For further information on Roquefort Therapeutics, please visit www.roquefortplc.com and @RoquefortTherap on Twitter.

LEI: 254900P4SISIWOR9RH34

About Roquefort Therapeutics

Roquefort Therapeutics (LSE:ROQ) is a Main Market listed biotech company developing products through the pre-clinical phase prior to partnering or selling to big pharma. The Company is a pre-clinical biotech company focused on developing first in class Midkine targeting drugs for the treatment of cancer.

Through extensive research resulting in validation through publication in over 1,000 scientific journals, Roquefort Therapeutics has identified the potential to exploit the broad therapeutic potential of Midkine for a number of clinical indications of unmet needs. Roquefort Therapeutics holds an exclusive licence to the largest global IP portfolio on Midkine. The Midkine blocking drug development markets have significant global market potential (in the multi-billion dollars). Roquefort Therapeutic's pre-clinical program is currently underway with an initial focus on cancer.

This announcement contains inside information for the purposes of Article 7 of the UK version of Market Regulation (EU) No 596/2014 on Market Abuse as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK MAR").

The notifications below, made in accordance with the requirements of the UK MAR, provides further detail:

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                               Jean Duvall 
      ---------------------------------  ----------------------------------------- 
       Reason for the notification 
  2 
      ---------------------------------------------------------------------------- 
 a)    Position/status                    Non-Executive Director 
      ---------------------------------  ----------------------------------------- 
 b)    Initial notification               Initial 
        /Amendment 
      ---------------------------------  ----------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                               Roquefort Therapeutics plc 
      ---------------------------------  ----------------------------------------- 
 b)    LEI                                254900P4SISIWOR9RH34 
      ---------------------------------  ----------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4     for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description of the                 Warrants (exercise price of 15 pence) 
        financial instrument, 
        type of instrument                 ISIN: GB00BMDQ2T15 
        Identification code 
      ---------------------------------  ----------------------------------------- 
 b)    Nature of the transaction          Issue of warrants 
      ---------------------------------  ----------------------------------------- 
 c)    Price(s) and volume(s)             Price(s)                     Volume(s) 
      ---------------------------------  ----------------------------  ----------- 
   15 pence per share                                                  300,000 
  -------------------------------------------------------------------  ----------- 
 d     Aggregated information 
        - Aggregated volume                       *    300,000 
        - Price 
 
                                                  *    15p 
      ---------------------------------  ----------------------------------------- 
 e)    Date of the transactions           22 June 2022 
      ---------------------------------  ----------------------------------------- 
 f)    Place of the transactions          Outside a trading venue 
      ---------------------------------  ----------------------------------------- 
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                               Simon Sinclair 
      ---------------------------------  ----------------------------------------- 
       Reason for the notification 
  2 
      ---------------------------------------------------------------------------- 
 a)    Position/status                    Non-Executive Director 
      ---------------------------------  ----------------------------------------- 
 b)    Initial notification               Initial 
        /Amendment 
      ---------------------------------  ----------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      ---------------------------------------------------------------------------- 
 a)    Name                               Roquefort Therapeutics plc 
      ---------------------------------  ----------------------------------------- 
 b)    LEI                                254900P4SISIWOR9RH34 
      ---------------------------------  ----------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4     for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ---------------------------------------------------------------------------- 
 a)    Description of the                 Warrants (exercise price of 15 pence) 
        financial instrument, 
        type of instrument                 ISIN: GB00BMDQ2T15 
        Identification code 
      ---------------------------------  ----------------------------------------- 
 b)    Nature of the transaction          Issue of warrants 
      ---------------------------------  ----------------------------------------- 
 c)    Price(s) and volume(s)             Price(s)                     Volume(s) 
      ---------------------------------  ----------------------------  ----------- 
   15 pence per share                                                  300,000 
  -------------------------------------------------------------------  ----------- 
 d     Aggregated information 
        - Aggregated volume                       *    300,000 
        - Price 
 
                                                  *    15p 
      ---------------------------------  ----------------------------------------- 
 e)    Date of the transactions           22 June 2022 
      ---------------------------------  ----------------------------------------- 
 f)    Place of the transactions          Outside a trading venue 
      ---------------------------------  ----------------------------------------- 
 
, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEDZGZVKZGGZZM

(END) Dow Jones Newswires

June 22, 2022 11:42 ET (15:42 GMT)

Roquefort Therapeutics (LSE:ROQ)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Roquefort Therapeutics Charts.
Roquefort Therapeutics (LSE:ROQ)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Roquefort Therapeutics Charts.